Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/280812 
Erscheinungsjahr: 
2023
Schriftenreihe/Nr.: 
ECIPE Policy Brief No. 05/2023
Verlag: 
European Centre for International Political Economy (ECIPE), Brussels
Zusammenfassung: 
It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its competitiveness has been going down for several decades - and, in more recent time, the pace of the decline is now accelerating. Europe is not just outpaced by the United States. Unless there is a new direction, China will soon be ahead of Europe too.
Dokumentart: 
Research Report

Datei(en):
Datei
Größe
284.85 kB





Publikationen in EconStor sind urheberrechtlich geschützt.